The provocative findings of a small Chinese randomized controlled trial that compared a full-dose and a half-dose regimen of lytics in patients with acute pulmonary embolism raise many questions and ...

Pulmonary embolism (PE) is caused by emboli, which have originated from venous thrombi, travelling to and occluding the arteries of the lung. PE is the most dangerous form of venous thromboembolism, ...

Marc Simon has reviewed the fundamental concepts underlying the diagnosis and therapy of a variety of clinical conditions associated with right ventricular (RV) failure (Simon, M. A. Assessment and ...

Researchers report that a new nuclear medicine tracer may allow better diagnosis of acute venous thromboembolism (VTE). Acute VTE is a disease that includes deep-vein thrombosis and its complication, ...

The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the role of ...

Stakeholders concurred that the occurrence of VTE events is a significant public health concern. According to Ralph J. Riello III, PharmD, “It is a problem often that hospitals do not know that they ...

The factor Xa inhibitor apixaban is noninferior to conventional therapy with enoxaparin and a vitamin K antagonist in patients with acute venous thromboembolism (VTE). The study, published online July ...

The Christian Medical College launches APERT to optimize acute pulmonary embolism care on World Thrombosis Day.

Imaging findings of in situ pulmonary artery thrombosis associated with radiation therapy are different from acute pulmonary emboli and do not appear to embolize Leesburg, VA, October 9, ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...